Navigation Links
Versus Technology, Inc. Announces Collaboration with Cleveland Clinic to Create Clinical Patient Flow Model
Date:4/21/2008

flow and medical assets and to improve caregiver/patient communications in medical and long-term care facilities. Versus also supplies Active IR/RFID tags and readers that make locating systems more precise, security systems more intelligent, data collection routines automatic, and asset management systems more efficient. Versus' systems, which are currently installed in hospitals, corporate facilities, government facilities, and other complexes, permit the automatic and accurate registry of essential management and business information. By monitoring the precise location of personnel or equipment and automatically recording events associated with their locations, the systems offer real-time asset and staff locating, automatic data collection, access/egress control, and a passive source of location data that facilitates scheduling and communication interfaces.

Safe Harbor Provision

This document may contain forward-looking statements relating to future events, such as the development of new products, the commencement of production, or the future financial performance of the Company. These statements fall within the meaning of forward-looking information as defined in the Private Securities Litigation Reform Act of 1995. These statements are subject to a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, economic, competitive, governmental, and technological factors affecting the Company's markets and market growth rates, products and their rate of commercialization, services, prices and adequacy of financing, and other factors. The Company undertakes no obligation to update, amend, or clarify forward-looking statements, whether because of new information, future events, or otherwise.


'/>"/>
SOURCE Versus Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Versus Technology Announces Fourth Quarter Results
2. Smart Home Cleaning: New Web Site Educates Consumers on Looking Clean Versus Being Clean
3. Occlutech Wins Confirmation of its Intellectual Property Position Versus AGA Medical Patent by AIPPI
4. Versus Technology Announces First Quarter Results
5. Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006
6. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
7. Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry
8. ZonePerfect(R) Survey Finds Americans Are Overfed on Technology, Underfed at the Dinner Table
9. eResearchTechnology, Inc. to Announce 2007 Third Quarter Results on November 1, 2007
10. Charles Alan Launches Healthcare-focused Furniture Lines with NuBax Seating Technology, Offering Smart Design and Health Benefits
11. eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...TON, Nov. 21 The Unive...d the beginning of a collaborative effort to eradi...ip for Breast Cancer Awareness and Research of the...irst Lady of the United States, and Vivian Fernand... Joining M. D. Anderson in the initiative are th...
(Date:11/21/2008)...MBIA, S.C., Nov. 21 U.S...ee for Quality Assurance (NCQA) ranked BlueChoice(...f America,s Best Health Plans(TM), published in U.... , The respected annual ranking ranks the nati...member satisfaction and NCQA accreditation scores....
(Date:11/21/2008)...y found 2 popular drugs do not cause genetic damag...ov. 21 (HealthDay News) -- Two popular medications...rder (ADHD) do not cause genetic damage linked to ...dy says. , The study, done by researchers at Du...itutes of Health, counters a previous one that rep...
(Date:11/21/2008)...YORK, Nov. 21 /PRNewswire/ -- For the second ye...ars , McCann Healthcare Worldwide,s agency networ...etwork at the 22nd annual international RX Club Sh...gency offices won a total of 59 RX Club Awards of ...inning McCann Healthcare Worldwide agencies includ...
Breaking Medicine News(10 mins):Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4
...study shows a clear link between fast food consump...sting that // fast food increases the risk of obes...the association between reported fast food habits ...insulin resistance over 15 years. The diets of mor...
...nk between migraines and the risk of coronary hear...t study shows // no link between the two but does ...est pain, also known as angina. People with a hist... aura -- seeing what appears to be spots or lines ...
...t form of macular degeneration represents about 10...lated macular degeneration is the leading cause of...rs of age and older. // Two new studies show a the...n effective treatment for age-related, "wet" macul...
..., more intense physical activity can help maintain...rchers according to // a new study. For the study ...1900 and 1920 from the Finland, Italy, and Netherl...ty of physical activities of the participants was ...
Other Medicine News:
(Date:11/20/2008)...P LINE RESULTS OF FIRST PHASE III TRIAL SHOW SIGNI...PROVEMENT IN DAILY FUNCTION, IN, ... Calif., and BRUSSELS, Belgium, Nov. 20 /PRNewswir...q: JAZZ ) and UCB (Euronext Brussels: UCB),anno...from the first of two,Phase III pivotal clinical ...
(Date:11/20/2008)...Nov. 20 Duska Therapeuti...oday that it has submitted its,pivotal Phase 3 AT...ecial,Protocol Assessment (SPA) procedure with th... Subject to securing an agreement with the FDA, ...double-blind, placebo-controlled and randomized Ph...
(Date:11/20/2008)..., November 20 The Scandinavian-bas...nnounced results of studies on its,lead antimicro...ington, DC,the studies showed that the novel lyt...l effect, significantly better towards killing Sta...n marketed gold standard drugs. In,addition to th...
(Date:11/19/2008)...s report basic findings on critical enzyme,s regul...treat an array of disorders , , MEMPHIS, Te...s at St. Jude Children,s Research Hospital have ga...dy,s enzyme workhorses called calpains. , , ...function in many cellular processes, including the...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3New research about chronic lung disease presented at CHEST 2008 27898 1New research about chronic lung disease presented at CHEST 2008 27898 2New research about chronic lung disease presented at CHEST 2008 27898 3New research about chronic lung disease presented at CHEST 2008 27898 4New research about chronic lung disease presented at CHEST 2008 27898 5New research about chronic lung disease presented at CHEST 2008 27898 6New research about chronic lung disease presented at CHEST 2008 27898 7CHEST 2008 3A Featured abstracts 27895 1CHEST 2008 3A Featured abstracts 27895 2CHEST 2008 3A Featured abstracts 27895 3CHEST 2008 3A Featured abstracts 27895 4CHEST 2008 3A Featured abstracts 27895 5CHEST 2008 3A Featured abstracts 27895 6CHEST 2008 3A Featured abstracts 27895 7CHEST 2008 3A Featured abstracts 27895 8CHEST 2008 3A Featured abstracts 27895 9CHEST 2008 3A Featured abstracts 27895 10CHEST 2008 3A Featured abstracts 27895 11CHEST 2008 3A Featured abstracts 27895 12CHEST 2008 3A Featured abstracts 27895 13CHEST 2008 3A Featured abstracts 27895 14CHEST 2008 3A Featured abstracts 27895 15CHEST 2008 3A Featured abstracts 27895 16CHEST 2008 3A Featured abstracts 27895 17CHEST 2008 3A Featured abstracts 27895 18Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing Tuskegee Effect When Recruiting Minorities for Research Studies 27894 1Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing Tuskegee Effect When Recruiting Minorities for Research Studies 27894 2Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing Tuskegee Effect When Recruiting Minorities for Research Studies 27894 3Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing Tuskegee Effect When Recruiting Minorities for Research Studies 27894 4Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing Tuskegee Effect When Recruiting Minorities for Research Studies 27894 5AUL Action Releases Open Letter to Sen Obama 3A Why do you oppose parental notification laws that protect our children from sexual abuse 3F 27891 1
...tivity and Metabolic,Enzymes Show How Cells Respon..., a Key Player in the Daily Biochemical Routines t...PRNewswire/ -- Investigators at,St. Jude Children,...namic genetic and biochemical changes that make up...led Coenzyme A (CoA), a key,player in metabolism. ...
... - Pfizer said today that,results from two new ima...d the progression of atherosclerosis in patients w...terolemia (FH). The,trials, which were designed to...ional compound torcetrapib in combination with,Lip...ay at the,annual meeting of the American College o...
Other Medicine Technology:Study Shows Metabolic Strategy of Stressed Cell 2Study Shows Metabolic Strategy of Stressed Cell 3Two New Imaging Studies Show Higher Dose Lipitor Stopped the,Progression of Atherosclerosis 2Two New Imaging Studies Show Higher Dose Lipitor Stopped the,Progression of Atherosclerosis 3Two New Imaging Studies Show Higher Dose Lipitor Stopped the,Progression of Atherosclerosis 4Two New Imaging Studies Show Higher Dose Lipitor Stopped the,Progression of Atherosclerosis 5
...cardial permanent pacing leads with an extendable/...y size of only 4.8 F and a lead tip size of 7 F, t...table bipolar pacing lead available today. Availab...s, Physique leads are ideal for placement in the a...
Implantable medical grade silicone sleeve for adapting a 5 mm (01) connector to a 6 mm (02) connector.
...nciple has been applied to cardiac resynchronizati..., which consists of the Tupos LV/A+ and the five-p...y and the risk of complications. The ICD receives ...ngle lead. The atrial input stage of the Tupos LV/...
...nchronization therapy defibrillator provides ventr...ronization therapy. Features: Independently progra... (LV) pacing and sensing. Designed to reduce irreg... arrhythmias. Designed to maintain atrial-tracked ...
Medicine Products: